Additional file 6: of Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

Authors :: Pochopien, Michal
Beiderbeck, Annette
McEwan, Phil
Zur, Richard
Mondher Toumi
Aballéa, Samuel
Publication Year :: 2019
Publisher :: figshare, 2019.
Abstract: Figure S5. Results of deterministic sensitivity analyses, FAc 0.2 μg/day implant vs. dexamethasone in pseudophakic population. (DOCX 31 kb)

Full Text Access

Tools